Ads
related to: pfizer
Search results
Pfizer Inc.’s latest rating changes from various analysts – Knox Daily
Knox Daily· 2 days agoPfizer Inc.’s recently made public that its Director Gottlieb Scott acquired Company’s shares for reported $79401.0 on Dec 15 ’23. In the deal valued at $26.47 per share,3,000 ...
UPDATE 1-Pfizer offers up to $250 mln to settle Zantac cancer lawsuits, FT reports
Reuters via Yahoo Finance· 7 days agoPfizer will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its discontinued heartburn drug Zantac, the Financial Times reported ...
China-Based Asymchem Laboratories Will Operate Former Pfizer Manufacturing Facility in UK
Morningstar· 22 hours agoBy Adriano Marchese Asymchem Laboratories (TianJin) said it will operate the former small molecule active pharmaceutical pilot plant that belonged to Pfizer UK, expanding ...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters· 5 days agoModerna said on Friday the European Patent Office had upheld the validity of one of the company's...
FCB Chicago lays off staff after losing Pfizer ad account
Crain s Chicago Business· 16 hours agoThe Interpublic Group of Cos. agency cuts 9% of staff after losing creative work from the pharma giant earlier this year.
Pfizer offers up to $250 mln to settle thousands of Zantac cancer lawsuits, FT reports
Reuters via Yahoo Finance· 7 days agoMay 16 (Reuters) - Pfizer has agreed offer payment of up to $250 million to settle more than 10,000 lawsuits in the United States over cancer risks associated with its now-discontinued ...
JD Supra: “Shadow Trading” is Insider Trading: Jury Establishes Liability in Historic Shadow Trading...
JD Supra· 33 minutes agoOn April 5, 2024, a jury found Matthew Panuwat civilly liable for insider trading in violation of federal securities laws in a first-of-its-kind “shadow trading” case (also referred to...
Spotlight on Pfizer: Analyzing the Surge in Options Activity - Pfizer (NYSE:PFE)
Benzinga· 6 days agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Pfizer PFE , and it's something market players shouldn't ignore. Our tracking of public ...
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
Reuters· 5 days ago, opens new tab $107.5 million in damages, a Delaware federal jury said on Friday after finding that...
Pfizer offers up to $250 million to settle Zantac cancer lawsuits, FT reports By Reuters
Investing.com· 7 days agoThe drugmaker was set to pay between $200 million and $250 million in the settlement, the newspaper...